Clinical Trial Update: Ketamine Plus Lithium in Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ketamine in combination with lithium for treatment-resistant depression has completed and posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-07-31